Depression in advanced cancer- ClinicalKey

  • Irving G
  • LLoyd-Williams M
N/ACitations
Citations of this article
1Readers
Mendeley users who have this article in their library.

Abstract

Purpose Depression is one of the most common psychiatric diseases seen in patients with advanced cancer. It is not only an independent predictor of poor survival in advanced cancer but also reduces quality of life, reduces compliance with treatment and prolongs hospitalization. Yet all too often depression is under diagnosed and under treated in this population. Method A literature review was undertaken using extensive electronic and hand searches. Key findings Whilst it is true that the diagnostic and treatment challenges facing healthcare professionals in this area are considerable one must not forget that depression in advanced cancer is treatable and validated assessment tools have been developed to facilitate diagnosis. Conclusions This review article provides the reader with a comprehensive review of the current evidence in this field with particular focus on assessment and treatment. Depression is under diagnosed and under treated – there are valid screening and assessment tools available which will allow appropriate management of this important and debilitating symptom.

Cite

CITATION STYLE

APA

Irving, G., & LLoyd-Williams, M. (2010). Depression in advanced cancer- ClinicalKey. European Journal of Oncology Nursing, 14(5), 395–399. Retrieved from https://www.clinicalkey.es/#!/content/journal/1-s2.0-S1462388910000360

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free